Globus Medical stockholders approve 2021 Equity Incentive Plan amendment at annual meeting

GLOBUS MEDICAL INC

At June 2, 2022 annual meeting, stockholders voted to approve amendment to the 2021 Equity Incentive Plan, effective immediately.
Directors David C. Paul, Daniel T. Lemaitre, and Ann D. Rhoads elected to three-year terms with strong stockholder support.
Deloitte & Touche LLP ratified as independent registered public accounting firm for fiscal 2022 (295,235,366 for).
Non-binding advisory vote on named executive officer compensation approved (283,414,921 for).
Plan amendment details (including share reserves, vesting, and award types) incorporated by reference from proxy statement filed April 21, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.